Helena Domin

972 total citations
42 papers, 819 citations indexed

About

Helena Domin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Helena Domin has authored 42 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Helena Domin's work include Neuroscience and Neuropharmacology Research (21 papers), Neuropeptides and Animal Physiology (13 papers) and Receptor Mechanisms and Signaling (10 papers). Helena Domin is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Neuropeptides and Animal Physiology (13 papers) and Receptor Mechanisms and Signaling (10 papers). Helena Domin collaborates with scholars based in Poland, South Korea and Japan. Helena Domin's co-authors include Maria Śmiałowska, Małgorzata Kajta, Barbara A. Zieba, Danuta Jantas, Bernadeta Szewczyk, Władysław Lasoń, Ewa Koźniewska, Monika Woźniak, Bartłomiej Pochwat and Joanna M. Wierońska and has published in prestigious journals such as Scientific Reports, Brain Research and The Journal of Physical Chemistry C.

In The Last Decade

Helena Domin

41 papers receiving 804 citations

Peers

Countries citing papers authored by Helena Domin

Since Specialization

Citations

This map shows the geographic impact of Helena Domin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Domin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Domin more than expected).

Fields of papers citing papers by Helena Domin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Domin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Domin. The network helps show where Helena Domin may publish in the future.

Co-authorship network of co-authors of Helena Domin

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Domin. A scholar is included among the top collaborators of Helena Domin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Domin. Helena Domin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuro- and vasoprotective potential of neuropeptide Y Y2 receptor agonist, NPY13-36, against transient focal cerebral ischemia in spontaneously hypertensive rats 2024 ·Neuroscience ·(unknown), Helena Domin, Maria Śmiałowska, Luiza Stanaszek, Paweł M. Boguszewski, Ewa Koźniewska	0
2	The antidepressant-like and glioprotective effects of the Y2 receptor antagonist SF-11 in the astroglial degeneration model of depression in rats: Involvement of glutamatergic inhibition 2023 ·Behavioural Brain Research ·Helena Domin, Jolanta Konieczny, Paulina Cieślik, Bartłomiej Pochwat, Elżbieta Wyska, Małgorzata Szafarz, Tomasz Lenda, (unknown), (unknown), Maria Śmiałowska, Bernadeta Szewczyk	4
3	Group III metabotropic glutamate receptors as promising targets for neuroprotective therapy: Particular emphasis on the role of mGlu4 and mGlu7 receptors 2022 ·Pharmacology Biochemistry and Behavior ·Helena Domin	14
4	Spectroscopic characterization and in vitro studies of biological activity of bradykinin derivatives 2022 ·Scientific Reports ·Leonard M. Proniewicz, Grzegorz Burnat, Helena Domin, (unknown), Adam Roman, Adam Prahl	3
5	Simultaneous activation of mGlu2 and muscarinic receptors reverses MK-801-induced cognitive decline in rodents 2019 ·Neuropharmacology ·Paulina Cieślik, Helena Domin, Agnieszka Chocyk, Piotr Gruca, Ewa Litwa, Agata Płoska, Adrianna Radulska, Iwona Pelikant‐Małecka, Piotr Brański, Leszek Kalinowski, Joanna M. Wierońska	13
6	Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension 2018 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Helena Domin, (unknown), Ewa Koźniewska, Paweł M. Boguszewski, Maria Śmiałowska	19
7	Involvement of extracellular signal-regulated kinase (ERK) in the short and long-lasting antidepressant-like activity of NMDA receptor antagonists (zinc and Ro 25-6981) in the forced swim test in rats 2017 ·Neuropharmacology ·Bartłomiej Pochwat, Anna Rafało-Ulińska, Helena Domin, Paulina Misztak, Gabriel Nowak, Bernadeta Szewczyk	26
8	SERS characterization of neuropeptide Y and its C-terminal fragments deposited onto colloidal gold nanoparticle surface 2016 ·Colloids and Surfaces B Biointerfaces ·Helena Domin, Natalia Piergies, (unknown), Ewa Pięta, Leonard M. Proniewicz	5
9	Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death 2015 ·Neurochemistry International ·Helena Domin, Danuta Jantas, Maria Śmiałowska	26
10	Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies 2015 ·Neuropharmacology ·Helena Domin, (unknown), Danuta Jantas, Ewa Koźniewska, Paweł M. Boguszewski, Maria Śmiałowska	37
11	Group III mGlu Receptor Agonist, ACPT-I, Exerts Potential Neuroprotective Effects In Vitro and In Vivo 2014 ·Neurotoxicity Research ·Helena Domin, Krystyna Gołembiowska, Danuta Jantas, Katarzyna Kamińska, Barbara A. Zieba, Maria Śmiałowska	18
12	Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression 2014 ·Behavioural Brain Research ·Helena Domin, Bernadeta Szewczyk, Monika Woźniak, (unknown), Maria Śmiałowska	36
13	Glial degeneration as a model of depression 2013 ·Pharmacological Reports ·Maria Śmiałowska, Bernadeta Szewczyk, Monika Woźniak, (unknown), Helena Domin	28
14	Alterations in the expression of nNOS in the substantia nigra and subthalamic nucleus of 6-OHDA-lesioned rats: The effects of chronic treatment with l-DOPA and the nitric oxide donor, molsidomine 2013 ·Brain Research ·Anna Czarnecka, Tomasz Lenda, Helena Domin, Jolanta Konieczny, Maria Śmiałowska, Elżbieta Lorenc‐Koci	20
15	Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin-and GABA-dependent 2011 ·Pharmacological Reports ·Katarzyna Stachowicz, Joanna M. Wierońska, Helena Domin, Shigeyuki Chaki, Andrzej Pilc	10
16	Selective mGluR1 Antagonist EMQMCM Inhibits the Kainate-Induced Excitotoxicity in Primary Neuronal Cultures and in the Rat Hippocampus 2011 ·Neurotoxicity Research ·Maria Śmiałowska, Krystyna Gołembiowska, Małgorzata Kajta, Barbara A. Zieba, Anna Dziubina, Helena Domin	25
17	Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats 2011 ·Neurochemistry International ·Elżbieta Lorenc‐Koci, Tomasz Lenda, Lucyna Antkiewicz‐Michaluk, Jadwiga Wardas, Helena Domin, Maria Śmiałowska, Jolanta Konieczny	29
18	Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo 2009 ·Neuropeptides ·Maria Śmiałowska, Helena Domin, Barbara A. Zieba, Ewa Koźniewska, (unknown), Piotr Piotrowski, Małgorzata Kajta	56
19	Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro 2009 ·Neurochemistry International ·Małgorzata Kajta, (unknown), Elżbieta Ziemińska, Danuta Jantas, Helena Domin, Władysław Lasoń, Andrzej Kutner, Jerzy W. Łazarewicz	63
20	Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: An involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3β intracellular signaling pathway 2007 ·Neuroscience ·Małgorzata Kajta, Helena Domin, Grzegorz Grynkiewicz, Władysław Lasoń	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact